IND filing and initial clinical data on first targeted Radio-DARPin therapy program, MP0712, expected in 2025; strategic partnership with Orano Med expanded from four to ten programs "Molecular ...

President Trump’s most recent annual physical revealed he’s in “excellent health,” going so far as to point to his “frequent ...

Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing ...

Prunes are not the only fruit you can eat to stimulate a bowel movement. Learn the best fruits to help with constipation and ...

Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an ...

Aisles of locked plastic cabinets in drug stores. Audiologists in the UK whose videos of cleaning skin and wax out of ...

The neurofibromatosis type 1 market remains niche, but awareness campaigns, increased diagnoses, and treatment adoption, along with ongoing clinical ...

Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous ...

We find out if this fitness supplement can be used to build muscle mass, decrease fatigue and improve mental health ...

After the wildfires in California last year, she had two-and-a-half liters of plasma removed from her body in an effort to ...

Pulmatrix, Inc. ("Pulmatrix" or the "Company") , a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and ...

Health Secretary Robert F. Kennedy Jr. is standing firm on the sweeping cuts to the Department of Health and Human Services, ...